BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ludwig J. The pathology of primary biliary cirrhosis and autoimmune cholangitis. Baillieres Best Pract Res Clin Gastroenterol. 2000;14:601-613. [PMID: 10976017 DOI: 10.1053/bega.2000.0106] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Gisbert JP, Jones EA, Pajares JM, Moreno-otero R. Is there an optimal therapeutic regimen for antimitochondrial antibody-negative primary biliary cirrhosis (autoimmune cholangitis)?: REVIEW: TREATMENT OF AUTOIMMUNE CHOLANGITIS. Alimentary Pharmacology & Therapeutics 2003;17:17-27. [DOI: 10.1046/j.1365-2036.2003.01381.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
2 R. Wanless I, M. Crawford J. Cirrhosis. Surgical Pathology of the GI Tract, Liver, Biliary Tract, and Pancreas. Elsevier; 2009. pp. 1115-45. [DOI: 10.1016/b978-141604059-0.50045-x] [Cited by in Crossref: 9] [Article Influence: 0.8] [Reference Citation Analysis]
3 Moreira RK, Revetta F, Koehler E, Washington MK. Diagnostic utility of IgG and IgM immunohistochemistry in autoimmune liver disease. World J Gastroenterol 2010; 16(4): 453-457 [PMID: 20101770 DOI: 10.3748/wjg.v16.i4.453] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
4 Hirschfield GM. Diagnosis of primary biliary cirrhosis. Best Pract Res Clin Gastroenterol. 2011;25:701-712. [PMID: 22117636 DOI: 10.1016/j.bpg.2011.10.005] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
5 Feng L, Dong K, Zhang X, Ma B, Chen L, Yang Q, Chen Q, Wen X, Jin Q. Clinical significance of IgG antimitochondrial M2 antibody levels in primary biliary cholangitis: A single center study from China. PLoS One 2020;15:e0242164. [PMID: 33180817 DOI: 10.1371/journal.pone.0242164] [Reference Citation Analysis]
6 Vierling JM. Primary biliary cirrhosis and autoimmune cholangiopathy. Clin Liver Dis. 2004;8:177-194. [PMID: 15062200 DOI: 10.1016/s1089-3261(03)00132-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
7 O'Donohue J, Wong T, Portmann B, Williams R. Immunohis-tochemical differences in the portal tract and acinar infiltrates between primary biliary cirrhosis and autoimmune cholangitis. Eur J Gastroenterol Hepatol. 2002;14:1143-1150. [PMID: 12362106 DOI: 10.1097/00042737-200210000-00016] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
8 Hirschfield GM, Heathcote EJ. Antimitochondrial antibody-negative primary biliary cirrhosis. Clin Liver Dis. 2008;12:323-331; viii-ix. [PMID: 18456183 DOI: 10.1016/j.cld.2008.02.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
9 李祥金, 杨晋辉. 原发性胆汁性肝硬化AMA-M2阴性患者的临床及病理特点. 世界华人消化杂志 2009; 17(16): 1676-1679 [DOI: 10.11569/wcjd.v17.i16.1676] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Wang L, Han Q, Chen H, Wang K, Shan GL, Kong F, Yang YJ, Li YZ, Zhang X, Dong F. Allogeneic bone marrow mesenchymal stem cell transplantation in patients with UDCA-resistant primary biliary cirrhosis. Stem Cells Dev. 2014;23:2482-2489. [PMID: 24835895 DOI: 10.1089/scd.2013.0500] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 5.7] [Reference Citation Analysis]
11 Floreani A, Spinazzè A, Caballeria L, Reig A, Cazzagon N, Franceschet I, Buja A, Furlan P, Harada K, Leung PS, Gershwin ME, Pares A. Extrahepatic malignancies in primary biliary cirrhosis: a comparative study at two European centers. Clin Rev Allergy Immunol 2015;48:254-62. [PMID: 25205363 DOI: 10.1007/s12016-014-8446-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 3.4] [Reference Citation Analysis]
12 Rocha HC, Vilela EG. Clinical aspects and prognosis of patients with inflammatory bowel disease associated with autoimmune liver diseases. Gastroenterol Hepatol 2021:S0210-5705(21)00153-9. [PMID: 34023469 DOI: 10.1016/j.gastrohep.2021.03.011] [Reference Citation Analysis]
13 Lüth S, Weiler-Normann C, Schramm C, Lohse AW. [Autoimmune liver diseases]. Internist (Berl). 2009;50:310-317. [PMID: 19225747 DOI: 10.1007/s00108-008-2254-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
14 Romero-gomez M, Wichmann I, Crespo J, Pares A, Rodrigo L, Alvarez A, Diago M, Pons-romero F, Sanchez-munoz D, Aguilar-reina J, Andrade RJ, Salmeron J, Sanchez-pobre P, Rebollo JM, Martin-vivaldi R, Castellano-megias V, Nunez-roldan A, Bruguera M; Spanish Group for the Study of Autoimmune Cholangitis+. Serum Immunological Profile in Patients with Chronic Autoimmune Cholestasis. Am J Gastroenterology 2004;99:2150-7. [DOI: 10.1111/j.1572-0241.2004.40416.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
15 Talwalkar JA, Lindor KD. Primary biliary cirrhosis. Lancet. 2003;362:53-61. [PMID: 12853201 DOI: 10.1016/s0140-6736(03)13808-1] [Cited by in Crossref: 230] [Cited by in F6Publishing: 61] [Article Influence: 12.8] [Reference Citation Analysis]
16 Selmi C, Coppel RL, Gershwin ME. Primary Biliary Cirrhosis. The Autoimmune Diseases. Elsevier; 2006. pp. 749-65. [DOI: 10.1016/b978-012595961-2/50057-3] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
17 Campsen J, Zimmerman M, Trotter J, Wachs M, Bak T, Steinberg T, Kaplan M, Kam I. Liver transplantation for primary biliary cirrhosis: results of aggressive corticosteroid withdrawal. Transplant Proc. 2009;41:1707-1712. [PMID: 19545712 DOI: 10.1016/j.transproceed.2008.10.095] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
18 Holtmeier J, Leuschner M, Schneider A, Leuschner U, Caspary WF, Braden B. 13C-methacetin and 13C-galactose breath tests can assess restricted liver function even in early stages of primary biliary cirrhosis. Scand J Gastroenterol. 2006;41:1336-1341. [PMID: 17060128 DOI: 10.1080/00365520600670125] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
19 Mendes F, Lindor KD. Antimitochondrial antibody-negative primary biliary cirrhosis. Gastroenterol Clin North Am. 2008;37:479-484, viii. [PMID: 18499032 DOI: 10.1016/j.gtc.2008.02.006] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]